Key facts
- It has raised $10.9M; the latest was Early Stage VC ($2.0M) in Apr 2025.
- Notable investors include Enterprise Ireland, Department of Enterprise, EIT Health, Fogarty Innovation, Ideate Ireland — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Amara Therapeutics
- ·The full record, as it builds
Funding rounds
No funding rounds for Amara Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Amara Therapeutics
Developer of a digital therapeutic platform designed for women to take care of their pelvic health. The company's technology helps in tracking patient-specific conditions and treatment strategies, provides pelvic floor muscle training, and expert-led education for pelvic and bladder health treatment, enabling pelvic health patients with affordable and effective care by providing evidence-based medicines.
- Sector
- Healthcare
- HQ
- Galway, Ireland
- Founded
- 2021
- Employees
- 9
- Website
- amaratherapeutics.com/
- Ownership
- Privately Held (backing)
Amara Therapeutics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Amara Therapeutics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Amara Therapeutics in its N-PORT filings yet. We sweep new filings monthly.